Logo image
IRO Home Research units Researcher Profiles
Sign in
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials
Journal article   Peer reviewed

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials

Lalitha K Shankar, John M Hoffman, Steve Bacharach, Michael M Graham, Joel Karp, Adriaan A Lammertsma, Steven Larson, David A Mankoff, Barry A Siegel, Annick Van den Abbeele, …
The Journal of nuclear medicine (1978), Vol.47(6), pp.1059-1066
06/2006
PMID: 16741317

View Online

Abstract

no abstract
United States Outcome Assessment (Health Care) - methods Prognosis Humans Treatment Outcome Positron-Emission Tomography - methods Neoplasms - diagnostic imaging Outcome Assessment (Health Care) - standards National Institutes of Health (U.S.) Neoplasms - therapy Positron-Emission Tomography - standards Fluorodeoxyglucose F18 Clinical Trials as Topic - standards Radiopharmaceuticals

Details

Metrics

Logo image